These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Nitration inhibits fibrillation of human alpha-synuclein in vitro by formation of soluble oligomers. Yamin G; Uversky VN; Fink AL FEBS Lett; 2003 May; 542(1-3):147-52. PubMed ID: 12729915 [TBL] [Abstract][Full Text] [Related]
4. Role of individual methionines in the fibrillation of methionine-oxidized alpha-synuclein. Hokenson MJ; Uversky VN; Goers J; Yamin G; Munishkina LA; Fink AL Biochemistry; 2004 Apr; 43(15):4621-33. PubMed ID: 15078109 [TBL] [Abstract][Full Text] [Related]
5. Inhibiting aggregation of alpha-synuclein with human single chain antibody fragments. Emadi S; Liu R; Yuan B; Schulz P; McAllister C; Lyubchenko Y; Messer A; Sierks MR Biochemistry; 2004 Mar; 43(10):2871-8. PubMed ID: 15005622 [TBL] [Abstract][Full Text] [Related]
6. Role of protein-water interactions and electrostatics in alpha-synuclein fibril formation. Munishkina LA; Henriques J; Uversky VN; Fink AL Biochemistry; 2004 Mar; 43(11):3289-300. PubMed ID: 15023080 [TBL] [Abstract][Full Text] [Related]
7. Nuclear localization of alpha-synuclein and its interaction with histones. Goers J; Manning-Bog AB; McCormack AL; Millett IS; Doniach S; Di Monte DA; Uversky VN; Fink AL Biochemistry; 2003 Jul; 42(28):8465-71. PubMed ID: 12859192 [TBL] [Abstract][Full Text] [Related]
8. Cleavage of alpha-synuclein by calpain: potential role in degradation of fibrillized and nitrated species of alpha-synuclein. Mishizen-Eberz AJ; Norris EH; Giasson BI; Hodara R; Ischiropoulos H; Lee VM; Trojanowski JQ; Lynch DR Biochemistry; 2005 May; 44(21):7818-29. PubMed ID: 15909996 [TBL] [Abstract][Full Text] [Related]
9. Rifampicin inhibits alpha-synuclein fibrillation and disaggregates fibrils. Li J; Zhu M; Rajamani S; Uversky VN; Fink AL Chem Biol; 2004 Nov; 11(11):1513-21. PubMed ID: 15556002 [TBL] [Abstract][Full Text] [Related]
10. The aggregation and fibrillation of alpha-synuclein. Fink AL Acc Chem Res; 2006 Sep; 39(9):628-34. PubMed ID: 16981679 [TBL] [Abstract][Full Text] [Related]
11. Rapid self-assembly of alpha-synuclein observed by in situ atomic force microscopy. Hoyer W; Cherny D; Subramaniam V; Jovin TM J Mol Biol; 2004 Jun; 340(1):127-39. PubMed ID: 15184027 [TBL] [Abstract][Full Text] [Related]
12. Impact of the acidic C-terminal region comprising amino acids 109-140 on alpha-synuclein aggregation in vitro. Hoyer W; Cherny D; Subramaniam V; Jovin TM Biochemistry; 2004 Dec; 43(51):16233-42. PubMed ID: 15610017 [TBL] [Abstract][Full Text] [Related]
13. A peptide motif consisting of glycine, alanine, and valine is required for the fibrillization and cytotoxicity of human alpha-synuclein. Du HN; Tang L; Luo XY; Li HT; Hu J; Zhou JW; Hu HY Biochemistry; 2003 Jul; 42(29):8870-8. PubMed ID: 12873148 [TBL] [Abstract][Full Text] [Related]
14. PA700, the regulatory complex of the 26S proteasome, interferes with alpha-synuclein assembly. Ghee M; Melki R; Michot N; Mallet J FEBS J; 2005 Aug; 272(16):4023-33. PubMed ID: 16098186 [TBL] [Abstract][Full Text] [Related]
15. Structural changes in alpha-synuclein affect its chaperone-like activity in vitro. Kim TD; Paik SR; Yang CH; Kim J Protein Sci; 2000 Dec; 9(12):2489-96. PubMed ID: 11206070 [TBL] [Abstract][Full Text] [Related]
16. Interaction of the molecular chaperone alphaB-crystallin with alpha-synuclein: effects on amyloid fibril formation and chaperone activity. Rekas A; Adda CG; Andrew Aquilina J; Barnham KJ; Sunde M; Galatis D; Williamson NA; Masters CL; Anders RF; Robinson CV; Cappai R; Carver JA J Mol Biol; 2004 Jul; 340(5):1167-83. PubMed ID: 15236975 [TBL] [Abstract][Full Text] [Related]
17. Structural evidence for alpha-synuclein fibrils using in situ atomic force microscopy. Zhang F; Ji LN; Tang L; Hu J; Hu HY; Xu HJ; He JH Acta Biochim Biophys Sin (Shanghai); 2005 Feb; 37(2):113-8. PubMed ID: 15685368 [TBL] [Abstract][Full Text] [Related]
18. The effect of macromolecular crowding on protein aggregation and amyloid fibril formation. Munishkina LA; Cooper EM; Uversky VN; Fink AL J Mol Recognit; 2004; 17(5):456-64. PubMed ID: 15362105 [TBL] [Abstract][Full Text] [Related]
19. Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein. Li J; Uversky VN; Fink AL Biochemistry; 2001 Sep; 40(38):11604-13. PubMed ID: 11560511 [TBL] [Abstract][Full Text] [Related]